NCCN 2013 Biomarkers Congress Webinar Series: Enriching Patient Populations for Clinical Trials (Molecular Profiling in Drug Development)
Biomarkers now play a key role in the routine management of patients with cancer and guide drug development in the age of targeted therapy.This webinar series will address the demand for reliable, practical information about biomarkers and their appropriate use, biomarker testing, application of test results, and clinical utility of biomarkers.
This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Identify challenges with identifying patient subsets with mutations appropriate for study
- Explain how molecular profiling can improve screening for clinical trials and enhance accrual
Phillip G. Febbo, MD
UCSF Helen Diller Family Comprehensive Cancer Center
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician